FIRST TRUST ADVISORS LP

Position in COLL — Collegium Pharmaceutical, Inc

CIK 1125816 Wheaton, IL

Position in COLL

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$6,309,442

+$5,797,675 QoQ

Shares Held

174,294

+907.1% QoQ

Ownership

0.535%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#39

of 280 holders

Holding Since

Sep 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. COLL ranks #13 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	923,125	$155,583,487
2	UTHR	UNITED THERAPEUTICS Corp	249,056	$134,946,012
3	ALKS	Alkermes plc.	2,421,016	$126,861,238
4	ZTS	Zoetis Inc.	1,435,652	$103,165,952
5	TAK	Takeda Pharmaceutical Co Ltd	2,114,912	$33,902,039
6	LQDA	Liquidia Corp	301,432	$24,033,173
7	BCRX	Biocryst Pharmaceuticals Inc	1,120,469	$11,204,690
8	AMRX	Amneal Pharmaceuticals, Inc.	614,206	$10,631,905

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,309,442	174,294	+907.1%	Shares	Sole	2026-08-11
2025-06-30	$511,767	17,307	-61.1%	Shares	Sole	2025-08-13
2025-03-31	$1,329,459	44,538	-65.7%	Shares	Sole	2025-05-14
2024-12-31	$3,715,647	129,691	-8.2%	Shares	Sole	2025-02-13
2024-09-30	$5,459,522	141,292	+14.9%	Shares	Sole	2024-11-13
2024-06-30	$3,959,666	122,971	+32.5%	Shares	Sole	2024-08-13
2023-06-30	$1,994,121	92,793	+3.8%	Shares	Sole	2023-08-14
2023-03-31	$2,144,202	89,379	+8.3%	Shares	Sole	2023-05-15
2022-12-31	$1,915,508	82,565	-8.4%	Shares	Sole	2023-02-09
2022-09-30	$1,444,010	90,138	+76.5%	Shares	Sole	2022-11-14
2022-06-30	$905,013	51,073	-4.4%	Shares	Sole	2022-08-12
2022-03-31	$1,087,936	53,435	-5.4%	Shares	Sole	2022-05-13
2021-12-31	$1,055,625	56,511	+11.5%	Shares	Sole	2022-02-08
2021-09-30	$1,000,225	50,670	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.